Memantine to prevent paclitaxel nerve damage in breast cancer
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether the drug memantine can help prevent or reduce nerve pain and other side effects caused by the chemotherapy drug paclitaxel in breast cancer patients. If you are about to start weekly paclitaxel, this study may offer extra protection to your nerves.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have breast cancer that has not spread to other parts of the body.
- You are scheduled to receive weekly paclitaxel (Taxol) as part of your treatment.
- You are able to perform daily activities (ECOG score 0-2).
- You do not have diabetes, nerve damage, or a history of seizures.
- You are not taking certain medications that affect nerves or interact with the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking vitamin D supplements can prevent nerve damage (a common side effect) caused by paclitaxel chemotherapy in women with early-stage breast cancer. If you have low vitamin D levels, you may be able to join.
This trial is testing two medications (memantine and rosuvastatin) that may protect your nerves from damage during chemotherapy. It is for people with stage III or IV colorectal cancer who are about to start a specific chemo regimen (FOLFOX or XELOX).
This trial tests whether taking two natural citrus compounds (hesperidin and diosmin) as daily pills can help prevent or reduce nerve damage (tingling, numbness, or pain in hands/feet) caused by the chemotherapy drug paclitaxel. If it works, it could make treatment more comfortable and improve your quality of life during breast cancer therapy.
This trial tests a gel applied to the skin that may help prevent nerve pain and numbness caused by common breast cancer chemotherapy drugs (paclitaxel and docetaxel). The goal is to see if the gel is safe and effective in reducing these side effects.
This trial tests whether a drug called GM1 can prevent nerve damage (numbness, tingling, or pain in hands/feet) caused by a common chemotherapy drug used for breast cancer. If you are starting chemotherapy with nab-paclitaxel, this study may help protect your nerves.
This study looks at whether certain markers in your blood can predict nerve damage from paclitaxel chemotherapy. If you join, researchers will monitor your nerve health during treatment to better understand and possibly prevent side effects.
Hear when a new Breast Cancer Early Stage Breast Cancer (Stage 1-3) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.